StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX - Free Report) in a research note issued to investors on Sunday morning. The firm issued a hold rating on the software maker's stock.
Separately, Stephens lifted their price target on Veradigm from $7.00 to $13.00 and gave the company an "equal weight" rating in a research report on Friday, January 31st.
Read Our Latest Stock Analysis on MDRX
Veradigm Trading Down 3.1 %
Shares of Veradigm stock traded down $0.14 during trading on Friday, hitting $4.35. The stock had a trading volume of 106 shares, compared to its average volume of 405,829. Veradigm has a 12 month low of $3.80 and a 12 month high of $11.80. The business's 50-day moving average is $4.45 and its 200 day moving average is $7.19.
Veradigm Company Profile
(
Get Free Report)
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Further Reading
Before you consider Veradigm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.
While Veradigm currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
